EEF2K and neoplasm: Therapeutic inhibition of eEF2K prevents tumor growth and enhances the efficacy of chemotherapy in pre-clinical TNBC models in mice [36], indicating that eEF2K is an important regulator of tumor growth and progression and a potential therapeutic target in TNBC.